Standout Papers

Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Recepto... 2006 2026 2012 2019 617
  1. Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib (2006)
    Gregory J. Riely, William Pao et al. Clinical Cancer Research

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 109 standout
Sub-graph 1 of 18

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
2018 Standout
25 intermediate papers

Works of DuyKhanh Pham being referenced

Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4
2007
Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
2006 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
DuyKhanh Pham 1037 675 292 9 1.2k
Karen J. Ferrante 734 853 355 18 1.2k
Thomas Goddemeier 912 946 339 18 1.3k
Swan-Swan Leong 1245 1022 319 11 1.5k
Anita Midha 914 961 238 16 1.3k
Rocco Sacco 862 650 385 12 1.2k
Symantha Melemed 1127 969 234 15 1.3k
Ira A. Oliff 1189 1256 443 12 1.7k
Claud Grigg 662 1139 214 21 1.5k
Mark Stoopler 830 702 177 17 1.1k
Valerie K. Israel 895 861 267 17 1.2k

All Works

Loading papers...

Rankless by CCL
2026